PANDA-Regional Feasibility Study of a Smartphone Pain Management Application

Postoperative Pain Clinical Trial

Official title:

The At-home Feasibility Evaluation of PANDA-Regional, a Smartphone Application Designed to Support Post-operative Pain Management in Patients Undergoing Peripheral Nerve Blocks

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03369392
• Other study ID #: H16-1196
• Status: Completed
• Phase: N/A
• Start date: December 11, 2017
• Est. completion date: March 31, 2019

Study information

• Verified date: April 2019
• Source: University of British Columbia
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Despite the numerous benefits of peripheral nerve blocks (PNBs) over general anesthesia (GA) in a variety of surgical procedures, PNBs can be associated with increased post-operative pain if pain medications are not taken correctly (titrated). Unfortunately, this is a common occurrence as patients often have difficulty titrating medications in the absence of direct medical care. PANDA, a smartphone-based postoperative pain management tool, is designed to address this issue by helping patients manage their pain medications. The purpose of this study is to demonstrate the feasibility of this application in patients who are discharged after receiving PNBs. The goal is to identify areas of improvement for the application itself. It is hypothesize that PANDA will be successful in supporting patients' postoperative pain management.

Description:

As above

Recruitment information / eligibility

• Status: Completed
• Enrollment: 29
• Est. completion date: March 31, 2019
• Est. primary completion date: March 31, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 19 Years to 75 Years

Eligibility

Inclusion Criteria:

• Undergoing ambulatory surgical procedures that require peripheral nerve blocks for which there is an anticipated post-surgical pain model

• Planned post-discharge analgesic medications including non-steroidal anti-inflammatory drugs, acetaminophen and/or opioids for at least 2 days

• ASA I-III

• Written informed consent

• Have a smartphone device at their disposal

Exclusion Criteria:

• Inability or refusal to provide informed consent

• Presence of significant cognitive impairment, visual impairments, neurological injury, or psychomotor dysfunction that impairs ability to use the app

• Inability to follow study instructions and complete questionnaires in English

Related Conditions & MeSH terms

• Anesthesia, Conduction
• Pain, Postoperative
• Postoperative Pain

Intervention

Other:
• Panda application
A smartphone-based postoperative pain management tool

Locations

Country	Name	City	State
Canada	St. Paul's Hospital	Vancouver	British Columbia

Sponsors (1)

Lead Sponsor	Collaborator
University of British Columbia

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Feasibility of the PANDA application	Measured by assessing the participants' compliance with the application in supporting ongoing pain assessments and analgesic administration.	2-7 days post-operatively
Secondary	Identify usability issues	Assessed by having participants complete a Computer Systems Usability Questionnaire (CSUQ) and a brief phone interview	2-7 days post-operatively